中文     English
Hunan Er-Kang Pharmaceutical (300267) will acquire 47.297% equity of Liaocheng Pharmaceutical with 48,250,000RMB (US $8,041,667)

 

Hunan Er-Kang Pharmaceutical (300267) intends to acquire 47.297% equity of Liaocheng Pharmaceutical with 48,250,000RMB (US $8,041,667) and is required to make a down payment of 14,470,000RMB (US $2,411,667). After this acquisition, Er-Kang Pharmaceutical will integrate its industry resources, improve its industry layout, and enhance its core competencies.

 

For more information, please contact us at david.chen@bfcgroup.biz